Un panel de la FDA respalda a la vacuna contra el VSR de Pfizer para los estadounidenses mayores
MIÉRCOLES, 1 de marzo de 2023 (HealthDay News) — En un apretado voto, los asesores de la Administración de Alimentos y Medicamentos (FDA) de EE. UU. recomendaron el martes la aprobación de una vacuna contra el virus sincitial respiratorio (VSR) que s…
Learn MoreCOVID Lockdowns Linked to Decline in Premature Births
THURSDAY, March 2, 2023 (HealthDay News) — Premature births dropped during lockdowns in the early months of the COVID-19 pandemic. A groundbreaking study, which included a group of mostly high-income countries — including the United States, Belgium, …
Learn MoreLong COVID Patients Show Lower Levels of Brain Oxygen
THURSDAY, March 2, 2023 (HealthDay News) — People who have long COVID — lingering symptoms after a COVID-19 infection — may also have lower brain oxygen levels, cognitive problems and psychiatric troubles, such as anxiety and depression.Researchers f…
Learn MoreIs an Allergy to a COVID Vaccine Always Real? Placebo Trial Casts Doubt
THURSDAY, March 2, 2023 (HealthDay) — Allergic reactions to the Pfizer or Moderna COVID vaccines are very rare, and a new study questions whether many of those that do occur are even real.In a small new study of 16 people who said they’d experienced …
Learn MoreFDA Panel Backs Second RSV Vaccine for Older Americans
THURSDAY, March 2, 2023 (HealthDay News) — Following hours of discussion over safety concerns, a U.S. Food and Drug Administration advisory panel on Wednesday recommended approval of a second RSV vaccine, this one made by GlaxoSmithKline, for use in …
Learn MoreFDA Panel Backs Pfizer’s RSV Vaccine for Older Americans
WEDNESDAY, March 1, 2023 (HealthDay News) — In a tight vote, U.S. Food and Drug Administration advisors on Tuesday recommended the approval of an RSV vaccine that could be used in Americans ages 60 and up. The vaccine, known as RENOIR, was developed …
Learn MoreLos riesgos cardiacos aumentan en las personas con COVID prolongada
JUEVES, 23 de febrero de 2023 (HealthDay News) — Sufrir los síntomas persistentes conocidos como COVID prolongada tras una infección con la COVID-19 multiplica por más de dos el riesgo de desarrollar nuevos síntomas cardiacos, según una investigación…
Learn MoreHeart Risks Rise in People With Long COVID
THURSDAY, Feb. 23, 2023 (HealthDay News) — Having the lingering symptoms known as long COVID after a COVID-19 infection more than doubles the risk of developing new heart symptoms, according to new research. “COVID-19 is more than a simple respirator…
Learn MoreUn beneficio adicional de la vacuna contra la COVID: un riesgo más bajo de ataque cardiaco si se infecta
LUNES, 20 de febrero de 2023 (HealthDay News) — Quizá una vacuna contra la COVID-19 proteja a una persona no solo del virus, sugiere una investigación reciente.Unos investigadores de la Escuela de Medicina Icahn de Mount Sinai, en la ciudad de Nueva …
Learn MoreIncluso una COVID leve podría cambiar al cerebro
MARTES, 21 de febrero de 2023 (HealthDay News) — Las personas que experimentan ansiedad y depresión meses después de un caso leve de COVID-19 podrían tener cambios que afectan a la estructura y la función de su cerebro, informan unos investigadores b…
Learn More